Menu
Back to User profile » Dr Ross A Baker
Papers published by Dr Ross A Baker:
Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies
Wigal SB, Wigal T, Hobart M, Madera JJ, Baker RA, Kohegyi E, McKinney A, Wilens TE
Neuropsychiatric Disease and Treatment 2020, 16:1411-1426
Published Date: 8 June 2020
Use of the Functioning Assessment Short Test (FAST) in defining functional recovery in bipolar I disorder. Post-hoc analyses of long-term studies of aripiprazole once monthly as maintenance treatment
Madera J, Such P, Zhang P, Baker RA, Grande I
Neuropsychiatric Disease and Treatment 2019, 15:2325-2338
Published Date: 15 August 2019
The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies
Peters-Strickland T, Baker RA, Such P, Zhang P, Madera JJ
Neuropsychiatric Disease and Treatment 2019, 15:1659-1669
Published Date: 24 June 2019
Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies
Madera JJ, Such P, Zhao C, Baker RA
Neuropsychiatric Disease and Treatment 2019, 15:1593-1604
Published Date: 18 June 2019
A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness
Kopelowicz A, Baker RA, Zhao C, Brewer C, Lawson E, Peters-Strickland T
Neuropsychiatric Disease and Treatment 2017, 13:2641-2651
Published Date: 19 October 2017
Digital health technology for use in patients with serious mental illness: a systematic review of the literature
Batra S, Baker RA, Wang T, Forma F, DiBiasi F, Peters-Strickland T
Medical Devices: Evidence and Research 2017, 10:237-251
Published Date: 4 October 2017
Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole
Peters-Strickland T, Pestreich L, Hatch A, Rohatagi S, Baker RA, Docherty JP, Markovtsova L, Raja P, Weiden PJ, Walling DP
Neuropsychiatric Disease and Treatment 2016, 12:2587-2594
Published Date: 11 October 2016
Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis
De Hert M, Eramo A, Landsberg W, Kostic D, Tsai LF, Baker RA
Neuropsychiatric Disease and Treatment 2015, 11:1299-1306
Published Date: 27 May 2015
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
Berman R, Thase M, Trivedi M, Hazel JA, Marler S, McQuade R, Carson W, Baker R, Marcus R
Neuropsychiatric Disease and Treatment 2011, 7:303-312
Published Date: 24 May 2011